Published in PLoS One on June 21, 2010
The antineoplastic effect of low-molecular-weight heparins - a literature review. Contemp Oncol (Pozn) (2013) 0.75
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer (2003) 22.78
Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature (2007) 7.87
The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer (2005) 5.98
The endothelial glycocalyx protects against myocardial edema. Circ Res (2003) 2.40
Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice. Nat Genet (2000) 2.23
Heparanase as mediator of angiogenesis: mode of action. FASEB J (2001) 2.04
Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Cancer Res (2006) 2.02
Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. Semin Cancer Biol (2008) 1.83
Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. J Clin Invest (1998) 1.83
Defects in keratinocyte activation during wound healing in the syndecan-1-deficient mouse. J Cell Sci (2002) 1.72
Role of glycocalyx in leukocyte-endothelial cell adhesion. Am J Physiol Heart Circ Physiol (2002) 1.66
The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer. Exp Cell Res (2005) 1.62
Inflammation and thrombosis. J Thromb Haemost (2003) 1.60
The endothelial glycocalyx: a potential barrier between health and vascular disease. Curr Opin Lipidol (2005) 1.53
Oxidized lipoproteins degrade the endothelial surface layer : implications for platelet-endothelial cell adhesion. Circulation (2000) 1.53
The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy. Blood (2007) 1.49
Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc Natl Acad Sci U S A (1996) 1.49
Inhibition of tumor growth in vivo by hyaluronan oligomers. Int J Cancer (1998) 1.35
Inhibition of tumor metastasis by heparanase inhibiting species of heparin. Invasion Metastasis (1995) 1.34
Endogenous activated protein C limits cancer cell extravasation through sphingosine-1-phosphate receptor 1-mediated vascular endothelial barrier enhancement. Blood (2009) 1.23
Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation. Cochrane Database Syst Rev (2007) 1.20
Mechanisms of heparin induced anti-cancer activity in experimental cancer models. Crit Rev Oncol Hematol (2006) 1.18
P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins. FASEB J (2007) 1.14
Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin. Thromb Haemost (2006) 1.09
Syndecan-1 deficiency aggravates anti-glomerular basement membrane nephritis. Kidney Int (2007) 1.05
Proteoglycan signaling co-receptors: roles in cell adhesion, migration and invasion. Cell Signal (2009) 1.04
Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders. J Cell Mol Med (2008) 1.03
Role of the heparan sulfate proteoglycan syndecan-1 (CD138) in delayed-type hypersensitivity. J Immunol (2009) 0.98
Heparanase, heparin and the coagulation system in cancer progression. Thromb Res (2007) 0.95
Chemically modified heparins as inhibitors of heparan sulfate specific endo-beta-glucuronidase (heparanase) of metastatic melanoma cells. Biochemistry (1986) 0.91
Pharmacokinetics and tissue distribution of bovine testicular hyaluronidase and vinblastine in mice: an attempt to optimize the mode of adjuvant hyaluronidase administration in cancer chemotherapy. Cancer Lett (1998) 0.91
Suppression of syndecan-1 expression in endothelial cells by tumor necrosis factor-alpha. J Biol Chem (1996) 0.88
High factor VIIa levels do not promote tumor metastasis. Thromb Haemost (2008) 0.85
Role of the glycosaminoglycan microenvironment of hyaluronidase in regulation of its endoglycosidase activity. Biochemistry (Mosc) (2003) 0.78
Long-term thrombin inhibition promotes cancer cell extravasation in a mouse model of experimental metastasis. J Thromb Haemost (2009) 0.77
Chemical modification of hyaluronidase regulates its inhibition by heparin. Eur J Pharm Biopharm (2001) 0.77
The fate of intravenously administered highly purified bovine testicular hyaluronidase (Hyalosidase) in the rat. Biochem Pharmacol (1985) 0.76
Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med (2013) 20.65
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet (2012) 12.10
Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation (2011) 6.47
Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology (2012) 6.04
Idarucizumab for Dabigatran Reversal. N Engl J Med (2015) 5.91
Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA (2006) 4.75
Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation (2007) 3.20
New approaches to the treatment of dense deposit disease. J Am Soc Nephrol (2007) 3.02
Repression of smoothened by patched-dependent (pro-)vitamin D3 secretion. PLoS Biol (2006) 2.35
The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta (2004) 2.30
Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism: a prospective cohort study. Ann Intern Med (2011) 2.28
Proximal tubular cells contain a phenotypically distinct, scattered cell population involved in tubular regeneration. J Pathol (2013) 2.12
Risk of deep vein thrombosis and pulmonary embolism in asthma. Eur Respir J (2012) 2.08
Protease-activated receptor 2 suppresses lymphangiogenesis and subsequent lymph node metastasis in a murine pancreatic cancer model. J Pathol (2014) 2.02
The multifunctional or moonlighting protein CD26/DPPIV. Eur J Cell Biol (2003) 1.98
In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma. Cancer Cell (2010) 1.94
Chromosome-wide nucleosome replacement and H3.3 incorporation during mammalian meiotic sex chromosome inactivation. Nat Genet (2007) 1.93
Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. Arterioscler Thromb Vasc Biol (2006) 1.87
Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia. Crit Care Med (2006) 1.82
Visualization of early events in tumor formation of eGFP-transfected rat colon cancer cells in liver. Hepatology (2003) 1.82
The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma. Acta Neuropathol (2010) 1.80
Asymmetry in histone H3 variants and lysine methylation between paternal and maternal chromatin of the early mouse zygote. Mech Dev (2005) 1.79
Therapeutic potential of fecal microbiota transplantation. Gastroenterology (2013) 1.78
The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy. PLoS One (2008) 1.68
Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways. Nucleic Acids Res (2003) 1.68
Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals. Biotechniques (2007) 1.66
Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes. Qual Life Res (2010) 1.61
Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Prog Retin Eye Res (2013) 1.61
Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am J Respir Crit Care Med (2005) 1.60
Role of the factor V Leiden mutation in septic peritonitis assessed in factor V Leiden transgenic mice. Crit Care Med (2006) 1.60
In vivo HP1 targeting causes large-scale chromatin condensation and enhanced histone lysine methylation. Mol Cell Biol (2005) 1.60
WEE1 kinase targeting combined with DNA-damaging cancer therapy catalyzes mitotic catastrophe. Clin Cancer Res (2011) 1.59
Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation. Crit Care Med (2005) 1.58
Statin treatment and the risk of recurrent pulmonary embolism. Eur Heart J (2013) 1.58
Retracted In vivo degradation of heparan sulfates in the glomerular basement membrane does not result in proteinuria. J Am Soc Nephrol (2007) 1.57
Cardiovascular risk assessment in haemophilia patients. Thromb Haemost (2010) 1.57
Molecular determinants of nucleosome retention at CpG-rich sequences in mouse spermatozoa. Nat Struct Mol Biol (2013) 1.54
Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients. Intern Emerg Med (2008) 1.54
Gene expression profiling identifies C/EBPdelta as a candidate regulator of endotoxin-induced disseminated intravascular coagulation. Am J Respir Crit Care Med (2007) 1.54
Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study. Arthritis Res Ther (2009) 1.44
Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity. Am J Pathol (2007) 1.43
Safety and feasibility of a diagnostic algorithm combining clinical probability, d-dimer testing, and ultrasonography for suspected upper extremity deep venous thrombosis: a prospective management study. Ann Intern Med (2014) 1.42
Sperm-derived histones contribute to zygotic chromatin in humans. BMC Dev Biol (2008) 1.39
Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran. Thromb Haemost (2015) 1.36
Glucose-6-phosphate dehydrogenase deficiency and malaria: cytochemical detection of heterozygous G6PD deficiency in women. J Histochem Cytochem (2009) 1.36
A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy. Br J Ophthalmol (2012) 1.33
Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Am J Pathol (2011) 1.30
Heparanase is essential for the development of diabetic nephropathy in mice. Diabetes (2011) 1.29
mTOR inhibitor treatment of pancreatic cancer in a patient With Peutz-Jeghers syndrome. J Clin Oncol (2010) 1.29
Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17. Arthritis Rheum (2009) 1.24
Publication bias in laboratory animal research: a survey on magnitude, drivers, consequences and potential solutions. PLoS One (2012) 1.23
Endogenous activated protein C limits cancer cell extravasation through sphingosine-1-phosphate receptor 1-mediated vascular endothelial barrier enhancement. Blood (2009) 1.23
Hedgehog: an unusual signal transducer. Bioessays (2004) 1.22
Cathepsin L, target in cancer treatment? Life Sci (2009) 1.22
Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome. J Biol Chem (2009) 1.21
Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system. J Am Soc Nephrol (2006) 1.19
Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways. Mol Med (2004) 1.18
Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus. Arthritis Rheum (2007) 1.18
Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: a systematic review. Thromb Res (2009) 1.17
Sonic hedgehog induces transcription-independent cytoskeletal rearrangement and migration regulated by arachidonate metabolites. Cell Signal (2007) 1.16
Activated protein C protects against myocardial ischemia/ reperfusion injury via inhibition of apoptosis and inflammation. Arterioscler Thromb Vasc Biol (2009) 1.15
Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation. Am J Pathol (2008) 1.13
The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight. Atherosclerosis (2009) 1.12
Isolation and characterization of conditionally immortalized mouse glomerular endothelial cell lines. Kidney Int (2004) 1.11
Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department. Crit Care Med (2010) 1.11
Heparan sulfate proteoglycans in glomerular inflammation. Kidney Int (2004) 1.10
Effect of VEGF-A on expression of profibrotic growth factor and extracellular matrix genes in the retina. Invest Ophthalmol Vis Sci (2007) 1.10
Coagulation factors VIIa and Xa inhibit apoptosis and anoikis. Oncogene (2004) 1.10
Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus. Ann Rheum Dis (2010) 1.10
Angiogenesis is not impaired in connective tissue growth factor (CTGF) knock-out mice. J Histochem Cytochem (2007) 1.10
Heparin blocks transfer of extracellular vesicles between donor and recipient cells. J Neurooncol (2013) 1.09
Microbial modulation of insulin sensitivity. Cell Metab (2014) 1.08
Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol (2009) 1.08
Statins, fibrates, and venous thromboembolism: a meta-analysis. Eur Heart J (2009) 1.08
Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness. Transplantation (2006) 1.07
CCAAT/enhancer-binding protein δ: multifaceted regulator in respiratory disease. Am J Pathol (2013) 1.07
Differential gene expression changes in children with severe dengue virus infections. PLoS Negl Trop Dis (2008) 1.06
Characterization of coagulation factor synthesis in nine human primary cell types. Sci Rep (2012) 1.06
Image cytometry: protocols for 2D and 3D quantification in microscopic images. Prog Histochem Cytochem (2012) 1.05
Antibody response against the glomerular basement membrane protein agrin in patients with transplant glomerulopathy. Am J Transplant (2005) 1.05
Protease-activated receptor-4 inhibition protects from multiorgan failure in a murine model of systemic inflammation. Blood (2007) 1.05
Disseminated intravascular coagulation. Hematol J (2003) 1.05
The role of dendritic cells in the pathogenesis of systemic lupus erythematosus. Arthritis Res Ther (2010) 1.04
Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study. Thromb Haemost (2012) 1.04
Incidental venous thromboembolism in cancer patients: prevalence and consequence. Thromb Res (2010) 1.04
The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease. J Biol Chem (2010) 1.03
Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes. Exp Eye Res (2009) 1.03
Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders. J Cell Mol Med (2008) 1.03
The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res Hum Genet (2009) 1.03
Markers of inflammation and coagulation indicate a prothrombotic state in HIV-infected patients with long-term use of antiretroviral therapy with or without abacavir. AIDS Res Ther (2010) 1.03
Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies. Mol Immunol (2009) 1.01
Factor Xa: at the crossroads between coagulation and signaling in physiology and disease. Trends Mol Med (2008) 1.01
Probiotics, prebiotics, and the host microbiome: the science of translation. Ann N Y Acad Sci (2013) 1.01
Genomics: A gut prediction. Nature (2013) 1.01
Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain. Blood (2011) 1.00
Epigenetic patterns maintained in early Caenorhabditis elegans embryos can be established by gene activity in the parental germ cells. PLoS Genet (2011) 1.00
Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded. Haematologica (2012) 1.00
CCAAT/enhancer-binding protein δ facilitates bacterial dissemination during pneumococcal pneumonia in a platelet-activating factor receptor-dependent manner. Proc Natl Acad Sci U S A (2012) 0.99